Christine Simmon | Association for Accessible Medicines
AAM Statement - President Trump’s Blueprint to Lower Drug Prices

Christine Simmon

Senior Vice President, Policy & Strategic Alliances
Executive Director, Biosimilars Council
Christine Simmon

Christine Simmon joined the Association for Accessible Medicines in 2012 as the Senior Vice President of Policy & Strategic Alliances and most recently was named Executive Director of AAM’s Biosimilars Council, founded in 2015.

In her current role, Christine is responsible for leading policy development and issues management for AAM, directing the Biosimilars Council, and building relationships with strategic partners in the health care sector, including patient advocacy groups.

Christine had previously served as Vice President of Policy, Public Affairs & Development at AAM from 2002 to 2006. Before rejoining the association, she was the Senior Director of Public Policy for CVS Caremark, where she was the policy lead for the integrated retail, convenient care clinic and pharmacy benefit manager enterprise at both the state and federal levels. Previously, Christine was a Senior Policy Analyst at BlueCross BlueShield Association, where she helped position the insurer as a leading voice on pharmaceutical cost and safety issues.

Christine received her J.D. from Georgetown University Law Center and her B.A. in American Studies from Georgetown University.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.